Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?

Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?

Source: 
Fierce Biotech
snippet: 

Allergies are an inconvenience at best and deadly at worst. But despite around one in three adults and one in four children having seasonal allergies, food allergies or eczema, according to statistics published in January 2023 by the Centers for Disease Control, it still isn’t entirely clear how and why they happen.